Grand Pharmaceutical Group Limited (0512) Financial Statements

4 Followers

Grand Pharmaceutical Group Limited Financial Overview

Grand Pharmaceutical Group Limited's market cap is currently HK$21.83B. The company's EPS TTM is HK$0.3505; its P/E ratio is 95.73; and it has a dividend yield of 3.13%. Grand Pharmaceutical Group Limited is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 12.28B	HK$ 11.64B	HK$ 10.53B	HK$ 9.56B	HK$ 8.60B
Gross Profit	HK$ 6.78B	HK$ 6.74B	HK$ 6.52B	HK$ 5.95B	HK$ 5.25B
Operating Income	HK$ 1.55B	HK$ 2.17B	HK$ 2.66B	HK$ 2.52B	HK$ 2.02B
EBITDA	HK$ 2.13B	HK$ 3.39B	HK$ 2.97B	HK$ 3.09B	HK$ 3.10B
Net Income	HK$ 1.24B	HK$ 2.47B	HK$ 1.88B	HK$ 2.08B	HK$ 2.40B
Balance Sheet
Cash & Short-Term Investments	HK$ 2.09B	HK$ 3.14B	HK$ 2.47B	HK$ 2.48B	HK$ 2.87B
Total Assets	HK$ 27.17B	HK$ 24.99B	HK$ 22.52B	HK$ 22.37B	HK$ 21.06B
Total Debt	HK$ 4.72B	HK$ 4.44B	HK$ 3.40B	HK$ 4.48B	HK$ 3.65B
Net Debt	HK$ 3.56B	HK$ 3.10B	HK$ 2.06B	HK$ 3.03B	HK$ 1.89B
Total Liabilities	HK$ 9.99B	HK$ 8.47B	HK$ 7.24B	HK$ 8.16B	HK$ 7.61B
Stockholders' Equity	HK$ 17.02B	HK$ 16.47B	HK$ 15.16B	HK$ 14.14B	HK$ 13.39B
Cash Flow
Free Cash Flow	HK$ 774.37M	HK$ 1.28B	HK$ 1.93B	HK$ 245.79M	HK$ 1.49B
Operating Cash Flow	HK$ 1.50B	HK$ 1.90B	HK$ 2.42B	HK$ 1.92B	HK$ 2.12B
Investing Cash Flow	HK$ -952.79M	HK$ -2.00B	HK$ -515.75M	HK$ -2.58B	HK$ -1.77B
Financing Cash Flow	HK$ -795.17M	HK$ 29.96M	HK$ -1.89B	HK$ 464.49M	HK$ -333.17M

Currency in HKD

Grand Pharmaceutical Group Limited Earnings and Revenue History

Income Statement >

Grand Pharmaceutical Group Limited Debt to Assets

Balance Sheet >

Grand Pharmaceutical Group Limited Cash Flow

Cash Flow >

Grand Pharmaceutical Group Limited Forecast EPS vs Actual EPS

Earnings >